Sambrook et al Molecular Cloning, A Laboratory Manual, pp. 13.15 and 13.17, 1989.* |
Bonaldo et al., Genome Res. 6:791-806, 1996* |
Lewin, Genes IV, Oxford University Press, p. 810, 1990.* |
Alberts et al., Molecular Biology of the Cell, third Ed. Carland Publishing, Inc. pp. 464-465, 1994.* |
The Promega Catalog, Nucleic Acids, 1994.* |
Hillier et al., “zd67g05.r1 soares fetal heart NbHH19W homo sapiens cDNA clone 345752 5',”Database EMBL-EMEST13 entry HS526369, Acc. No. W76526, 1996. |
Hoon, et al., “Human carcinoma associated HOJ-1 mRNA, complete eds.” Database EMBL-R57U005, Entry/Acc. No. U82396, Dec. 15, 1998. |
Marra et al., “mm45h12.r1 stratagene mouse melanoma (#937312) mus musculus cDNA clone 524519 5' similar to TR:G184390 G184390 putative transcritptional regulatory protein hrc 1,” EMBL-EMEST19 entry Mma68103, Jun. 23, 1996. |
Abbondanzo et al., “Prognostic significance of immunocytochemically determined ps2 in axillary nodenegative breast carcinoma,” Breast Cancer Res. Treat., 16:182, Abstract #151, 1990. |
Alfthan et al., “Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in the serum and urine of patient with malignant pancreatic and biliary disease,” Cancer Res., 52:4628-4633, 1992. |
Allred et al., “Comprehensive evaluation of prognostic factors by immunocytochemistry on extremely small samples (50 mg) of “pulverized” breast carcinomas,” Breast Cancer Res. Treat., 16:182, Abstract #149, 1990. |
Ando et al., “Ganglioside gm2 on the K562 cell line is recognized as target structure by human natural killer cells,” Int. J. Cancer, 40:12-17, 1987. |
Bitter et al., “Expression and secretion vectors for yeast,” Methods in Enzymol, 153:516-544, 1987. |
Brown et al., “Prognostic significance and clinical-pathological correlations of cell-cycle kinetic measured by KI-67 immunocytochemistry in axillary node-negative carinoma of the breast,” Breast Cancer Res. Treat., 16:192, Abstract #191, 1990. |
Capaldi et al., “Changes in order of migration of polypeptides in complex III and cytochrome c oxidase under different conditions of sds polyacrylamide gel electrophoresis,” Biochem. Biophys. Res. Comm., 74(2):425-433, 1977. |
Carubia et al., “Gangliosides of normal and neoplastic human melanocytes,” Biochem. Biophys. Res. Commun., 120:500-504, 1984. |
Chien et al., “The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest,” Proc. Nat'l. Acad. Sci. USA, 88:9578-9582, 1991. |
Chinault and Carbon, “Overlap hybridization screening: isolation and characterization of overlapping DNA fragments surrounding the leu2 gene on yeast chromosome III,” Gene, 5:111-126, 1979. |
Cohen, “Naked DNA points way to vaccines,” Science, 259:1691-1692, 1993. |
Cole et al., “Detection of the free beta subunit of human chorionic gonadotropin (HCG) in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma,” Endocrinology, 113:1176-1178, 1983. |
Datta et al., “Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction,” J. Clin. Oncol., 12:475-482, 1994. |
Denton et al., “A study of adhesion molecules as markers of progression in maglignant melanoma,” J. Pathol, 167(2):187-191, 1992. |
Diamond et al., “A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness,” J. Urol., 128:729-734, 1982. |
Donahue et al., “A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase,” J. Biol. Chem., 269:8604-8609, 1994. |
Dzau et al., “Fusigenic viral liposome for gene therapy in cardiovascular diseases,” Proc. Nat'l. Acad. Sci. USA, 93:11421-11425, 1996. |
Elder et al., “Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas,” Cancer Res., 49:5091-5096, 1989. |
Fearon et al., “Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism,” Am J Clin Nutr, 47(1):42-48, 1988. |
Fink et al., “Localization of the gene encoding the putative human HLA class II associated protein (PHAPI) to chromosome 15q22.3-q23 by fluorescence in situ hybridization” Genomics, 29:309-310, 1995. |
Furukawa et al., GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of β-1,4-N-acetylgalactosaminyltransferase gene by p40tax Proc. Nat'l. Acad. Sci. USA,90:1972-1976, 1993. |
Fynan et al., “DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations,” Proc. Nat'l. Acad. Sci. USA, 90:11478-11482, 1993. |
Gaugler et al., “Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes,” J. Exper. Med., 179:921-930, 1994. |
Gomella et al., “Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer,” J. Urolology, 158:326-337, 1997. |
Hollingsworth et al., “Expression of muc1, muc2, muc3, and muc4 mucin mRNAs in human pancreatic and intestinal tumor cell lines,” Int J Cancer, 57(2):198-203, 1994. |
Hoon et al., “Detection of metastatic breast cancer by β-hCG polymerase chain reaction,” Int J Cancer, 69(5):369-74, 1996. |
Hoon et al., “Detection of occult melanoma cells in blood with a multiple-maker polymerase chain reaction assay,” J. Clin. Oncol., 13:2109-2116, 1995. |
Hoon et al., “Melanoma paitents immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen,” J. Immunol., 154:730-737, 1995. |
Hoon et al., “Aberrant expression of gangliosides in human renal cell carcinomas,” J. Urol. , 150(6):2013-2018, 1993. |
Hoon et al., “Ganglioside gm2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells,” Int. J. Cancer, 43:857-862, 1989. |
Kohler and Milstein, “Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion,” Eur. J. Immunol. 6:511-519, 1976. |
Kohler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, 256:495-497, 1975. |
Kuo et al., “Assessment of Messenger RNA of β1→4-N-acetylgalactosaminyl-transferase as a molecular marker of metastatic melanoma,” Clin. Cancer Res., 4:411-418, 1998. |
Kwoh et al., “Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-base sandwich hybridization format,” Proc. Nat. Acad. Sci. USA, 86(4): 1173-1177, 1989. |
Kwon, B.S. “Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family,” J Invest. Dermatol., 100(2 Suppl):134S-140S, 1993. |
Lehmann et al., “MUC18, a marker of tumor progression in human melanoma, shows sequence similiarity to the neural cell adhesion molecules of the immunoglobulin superfamily,” Proc. Nat'l Acad Sci. USA, 86:9891-9895, 1989. |
Lehmann, et al., “Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,0001,” Cancer Res., 47:841-845, 1987. |
Li et al., “A huntingtin-associated protein enriched in brain with implications for pathology,” Nature, 378: 398-402, 1995. |
Liang and Pardee, “Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction,” Science, 257: 967-971, 1992. |
Liang et al., “Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells1,” Cancer Res., 52:6966-6968, 1992. |
Lin and Guidotti, “Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATpase,” J. Biol. Chem., 264:14408-14414, 1989. |
Madersbacher et al, “Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: insights into the in vivo hCG secretion pattern,” Cancer Res., 54:5096-5100, 1994. |
Marcillac et al., “Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms,” Cancer Res., 52:3901-3907, 1992. |
McManus et al., “Human chorionic gonadotropin in human neoplastic cells1,” Cancer Res., 36:3476-3481, 1976. |
Melcher and Johnson, “GAL4 interacts with TATA-binding protein and coactivators,” Mol. Cell Biol.,15:2839-2848, 1995. |
Mencinger et al., “Expression analysis and chromosomal mapping of a novel human gene, April, encoding an acidic protein rich in leucines,” Biochim. Biophys. Acta, 1395:176-180, 1998. |
Merrifield, “Solid phase synthesis,” Science, 232: 341-347, 1986. |
Mosmann, “Rapid Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” J. Immunol. Methods, 65:55-63, 1983. |
Nagata et al., “Expression cloning of β1,4 N-Acetylgalactosaminyltransferase cDNAs that determine the epxression of GM2 and GD2 gangliosides,” J. Biol. Chem, 267:12082-12089, 1992. |
Natali et al., “Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance,” Cancer, 59:55-63, 1987. |
Nordlund et al., “Pigment cell biology: an historial review,” J. Invest. Dermatol,. 92:53S-60S, 1989. |
Ohara et al., One-sided polymerase chain reaction: the amplification of cDNA, Proc. Nat'l Acad. Sci. USA, 86: 5673-5677, 1989. |
Pierce and Parsons, “Glycoprotein hormones: structure and function,” Ann. Rev. Biochem.50:465-495. 1981. |
Pinkel, et al., “Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization,” Proc Nat'l Acad Sci U S A, 83(9):2934-2938, 1986. |
Robbins et al., “Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy,” Cancer Res, 54(12):3124-3126, 1994. |
Rubinstein et al., “Comparison in vitro anticancer-drug-screening data generated with a tetraolium assay versus a protein assay against a diverse panel of human tumor cell lines,” J. Nat'l Cancer Inst., 82:1113-1120, 1990. |
Sarantou et al., “Melanoma-associated antigens as messenger RNA detection markers for melanoma,” Cancer Res, 57(7):1371-1376, 1997. |
Serrano et al., “A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4,” Nature, 366:704-707, 1993. |
Serrano et al., “Inhibition of ras-induced proliferation and cellular transformation by p16INK4,” Science, 267:249-252,1995. |
Sun and Cohen, “Computer-assisted drug discovery-a review,” Gene, 137:127-132, 1993. |
Talmadge et al., “Evolution of the genes for the βsubunits of human chorionic gonadotropin and luteinizing hormore,” Nature, 307:37-40, 1984. |
Tam et al., “SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis1,” J. Am. Chem. Soc., 105:6442, 1983. |
Tang et al., “Genetic immunization in a simple method for eliciting an immune response,” Nature, 356:152-154, 1992. |
Tsuchida et al., “Gangliosides of human melanoma,” J. Nat'l. Cancer Inst., 78:45-54, 1987. |
Tsuchida et al., “Gangliosides of human melanoma: GM2 and tumorigenicity,” J. Nat'l. Cancer Inst., 78:55-60, 1987. |
Van den Eynde et al., “A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma,” J. Exp. Med., 182:689-698, 1995. |
Van Der Bruggen et al., “A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma,” Science, 254:1643-1647, 1991. |
Van Pel et al., “Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis,” J. Exp. Med., 157:1992-2001, 1983. |
Vijayasardahi et al., “The melanoma antigen gp75 is the human homologue of the mouse β (Brown) locus gene product,” J. Experimental Medicine, 171(4):1375-1380, 1990. |
Wagner et al., “Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines,” Science, 260:1510-1513, 1993. |
Walker et al., “Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system,” Proc. Nat'l Acad Sci. USA, 89:392-396 1992. |
Weitzel and Patel, “A single P1 clone bearing three genes from human chromosome 11p15.5: HRC1, HRAS1, and RNH,” GATA, 11(5-6) 165-170, 1994. |
Weitzel et al., “The HRASI gene cluster: two upstream regions recognizing transcripts and a third encoding a gene with a leucine zipper domain,” Genomics, 14:309-319, 1992. |
Wu et al., “The ligation amplification reaction (LAR)-amplification of specific DNA sequences using sequential rounds of template-dependant ligation,” Genomics, 4(4):560-569, 1989. |
Yamaguchi et al., “Human chorionic gonadotropin a colorectal cancer and its relationship,” Br. J. Cancer, 60:382-384, 1989. |
Yoshimura et al., “Assessment of urinary β-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer,” Cancer, 73:2745-2752, 1994. |
Zhu et al., “Cloning and characterization of a new silver-stainable protein ssp29, a member of the Irr family,” Biochem. Mol. Biol. Int., 42:927-935, 1997. |